Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 49 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 13 Glioblastoma 10 Glioma 7 Astrocytoma 6 Carcinoma, Non-Small-Cell Lung 5 Urinary Bladder Neoplasms 4 Neoplasms 4 Brain Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Stomach Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Oligodendroglioma 2 Melanoma 2 Carcinoma 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Diseases 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Seroma 1 Rectal Neoplasms 1 Pleural Neoplasms 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Pleural Diseases 1 Patient Preference 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Inflammatory Breast Neoplasms 1

Interventions

Fluorouracil 21 Oxaliplatin 17 Leucovorin 17 Bevacizumab 17 Irinotecan 13 Panitumumab 12 Cetuximab 12 IFL protocol 9 Capecitabine 9 pembrolizumab 7 Radiotherapy 7 Pemetrexed 5 Gemcitabine 5 labetuzumab 3 conatumumab 3 Cisplatin 3 Carboplatin 3 Albumin-Bound Paclitaxel 3 5,11-methenyltetrahydrohomofolate 3 130-nm albumin-bound paclitaxel 3 vatalanib 2 trametinib 2 spartalizumab 2 pegfilgrastim 2 ganitumab 2 encorafenib 2 dostarlimab 2 Ramucirumab 2 Paclitaxel 2 Melphalan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Rectal Neoplasms × Surgical Procedures, Operative × Clear all

NCT00865189 2017-08-04

INOVA

Hoffmann-La Roche

Phase 2 Completed

91 enrolled 16 charts

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡